<DOC>
	<DOCNO>NCT00638859</DOCNO>
	<brief_summary>The primary objective ass safety telithromycin ( HMR3647 ) 20 mg/kg qd 5-7 day child community-acquired pneumonia ( CAP ) . Secondary objective assess Pharmacokinetics , Efficacy Acceptability telithromycin 20 mg/kg qd 5-7 day child CAP .</brief_summary>
	<brief_title>Japanese Study Evaluating Effects Telithromycin Children With Community-Acquired Pneumonia</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Telithromycin</mesh_term>
	<criteria>Subjects weigh 40 kg less . If female , premenarchal status require . Subjects diagnose CAP base chest Xray show presence new infiltrate , clinical symptom , laboratory finding . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Community-Acquired pneumonia</keyword>
	<keyword>CAP</keyword>
	<keyword>child</keyword>
	<keyword>Child</keyword>
</DOC>